Physician profile
Marc K Rybstein
NPI 1538393822
$1,231.04
in general payments reported to CMS, 2019-2025
20 companies · $90.52 in 2025
The $90.52 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $424 · 2020: $48.59 · 2021: $65.22 · 2022: $248 · 2023: $84.13 · 2024: $271 · 2025: $90.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $355.82 | 2019 | |
| Amgen INC. | $154.58 | 2020-2025 | Repatha, Repatha |
| Abbott Laboratories | $137.01 | 2022-2024 | Aveir |
| Novo Nordisk INC | $126.58 | 2021-2025 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $95.48 | 2021-2023 | Xarelto |
| Antares Pharma, INC. | $44.54 | 2022-2024 | Xyosted |
| Lilly USA, LLC | $43.16 | 2022-2024 | Zepbound, Jardiance |
| Alkermes, INC. | $41.30 | 2022-2023 | Vivitrol |
| Astrazeneca Pharmaceuticals LP | $35.30 | 2019-2023 | Farxiga |
| Inspire Medical Systems, INC. | $27.27 | 2024 | Inspire |
| Medtronic, INC. | $26.27 | 2024 | Ligasure |
| Philips North America LLC | $19.28 | 2024 | (Ck7) Extended Holter |
| Medtronic Vascular, INC. | $18.75 | 2019 | |
| Beta Bionics, INC. | $17.43 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Hologic Sales and Service, LLC | $17.37 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.92 | 2019 | |
| Esperion Therapeutics, INC. | $14.84 | 2022 | |
| Tolmar, INC. | $13.58 | 2024 | |
| Heartflow, INC. | $13.38 | 2024 | |
| Janssen Biotech, INC. | $12.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Rybstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.